Last updated: November 20, 2020
The following is a curated review of key information and literature about this topic. It is not comprehensive of all data related to this subject.
Overview
There are many therapeutics under early investigation for treatment of COVID-19 for which there is currently insufficient clinical data to recommend either for or against. This overview is not a comprehensive summary, but a list of therapeutics with strong biological plausibility that are available in the United States and are or will be studied by clinical trial.
*Published clinical studies (including preprints). Excludes case reports and case series.